Jerry S. Lanchbury
Plus aucun poste en cours
Profil
Jerry S.
Lanchbury is the founder of IR 2018 Ltd.
He worked as the Chief Scientific Officer at Myriad Genetics, Inc. from 2010 to 2022.
Prior to that, he held a former job at the same company from 2002 to 2010.
Lanchbury earned a doctorate degree from Newcastle University and an undergraduate degree from the University of Aston.
Anciens postes connus de Jerry S. Lanchbury
| Sociétés | Poste | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Chief Tech/Sci/R&D Officer | 14/01/2022 |
IR 2018 Ltd.
 IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services IR 2018 Ltd. develops human proteins for the treatment of rheumatoid arthritis. The company was founded by Gabriel S. Panayi and Jerry S. Lanchbury in August 6, 2001 and is headquartered in Great Shelford, the United Kingdom. | Founder | - |
Formation de Jerry S. Lanchbury
| Newcastle University | Doctorate Degree |
| University of Aston | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
IR 2018 Ltd.
IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services IR 2018 Ltd. develops human proteins for the treatment of rheumatoid arthritis. The company was founded by Gabriel S. Panayi and Jerry S. Lanchbury in August 6, 2001 and is headquartered in Great Shelford, the United Kingdom. | Commercial Services |
